Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

 Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -4.24% and the FTSE All-Share TR Index (£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

 The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

 Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

 24 April 2012 a total of 379,653 ordinary shares at a gross price of £2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

 Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

 

 

30 June 2012 

31 March 2012 

31 December 2011 

30 September 2011 

30 June 2011 

 

 

 

 

 

 

NAV

£2.93

£3.03

£2.79

£2.69

£2.96

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5685

 

1.5978

 

1.5541

 

1.5579

 

1.6055

 

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2012

 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

 

 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUCPRUPPGUQ
Date   Source Headline
24th Jul 20183:47 pmRNSAnnual Financial Report
19th Jul 20184:45 pmRNSNet Asset Value(s)
16th Jul 20183:35 pmRNSHolding(s) in Company
13th Jul 201810:14 amRNSHolding(s) in Company
6th Jul 20184:56 pmRNSDirector/PDMR Shareholding
22nd Jun 20183:28 pmRNSHolding(s) in Company
19th Jun 201810:56 amRNSNet Asset Value(s)
21st May 20182:17 pmRNSNet Asset Value(s)
27th Apr 201810:15 amRNSHolding(s) in Company
24th Apr 20187:00 amRNSHolding(s) in Company
18th Apr 20182:38 pmRNSHolding(s) in Company
18th Apr 20182:07 pmRNSNet Asset Value(s)
13th Apr 20183:52 pmRNSHolding(s) in Company
27th Mar 201810:33 amRNSNet Asset Value(s)
16th Mar 20184:53 pmRNSHolding(s) in Company
16th Mar 20184:09 pmRNSHolding(s) in Company
27th Feb 201810:49 amRNSNet Asset Value(s)
21st Feb 20182:35 pmRNSHoldings in Company
1st Feb 20188:38 amRNSTotal Voting Rights
31st Jan 20182:25 pmRNSHolding(s) in Company
31st Jan 20187:30 amRNSVoting Rights of Major Shareholders
31st Jan 20187:30 amRNSTransaction in Own Shares
29th Jan 20187:00 amRNSTransaction in Own Shares
26th Jan 201810:45 amRNSNet Asset Value(s)
24th Jan 201812:08 pmRNSHolding(s) in Company
2nd Jan 20185:22 pmRNSNet Asset Value(s)
2nd Jan 201810:38 amRNSTotal Voting Rights
22nd Dec 20177:00 amRNSTransaction in Own Shares
20th Dec 20177:00 amRNSTransaction in Own Shares
15th Dec 20173:48 pmRNSHalf-year Report
15th Dec 20177:00 amRNSTransaction in Own Shares
13th Dec 20174:51 pmRNSHolding(s) in Company
13th Dec 20173:25 pmRNSHolding(s) in Company
29th Nov 20172:40 pmRNSForm 8.3 - Servelec Group plc
24th Nov 201710:37 amRNSForm 8.3 - Servelec Group plc
23rd Nov 201712:40 pmRNSNet Asset Value(s)
24th Oct 20174:38 pmRNSNet Asset Value(s)
10th Oct 20171:42 pmRNSHolding(s) in Company
10th Oct 20177:00 amRNSHolding(s) in Company
21st Sep 20171:16 pmRNSNet Asset Value(s)
1st Sep 201711:30 amRNSResult of AGM
21st Aug 201712:09 pmRNSNet Asset Value(s)
17th Aug 20172:08 pmRNSHolding(s) in Company
8th Aug 20174:35 pmRNSTR-1: Notification of major interest in shares
1st Aug 20175:52 pmRNSTR-1: Notification of Major Interest in Shares
1st Aug 20175:08 pmRNSHolding(s) in Company
24th Jul 201711:50 amRNSNet Asset Value(s)
18th Jul 201710:47 amRNSAnnual Report and Accounts and Notice of AGM
7th Jul 201710:33 amRNSAnnual Financial Report
4th Jul 20171:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.